The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Treatment of hypertension in peripheral arterial disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2013
|
| DOI | 10.1002/14651858.cd003075.pub3 |
| Pubmed ID | |
| Authors |
Deirdre A Lane, Gregory YH Lip |
| Abstract |
Peripheral arterial disease (PAD) causes considerable morbidity and mortality. Hypertension is a risk factor for PAD. Treatment for hypertension must be compatible with the symptoms of PAD. Controversy regarding the effects of beta-adrenoreceptor blockade for hypertension in patients with PAD has led many physicians to stop prescribing beta-adrenoreceptor blockers. Little is known about the effects of other classes of anti-hypertensive drugs in the presence of PAD. This is the second update of a Cochrane review first published in 2003. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Egypt | 1 | 14% |
| United Kingdom | 1 | 14% |
| United States | 1 | 14% |
| Germany | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 272 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Ireland | 1 | <1% |
| Unknown | 270 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 43 | 16% |
| Student > Bachelor | 38 | 14% |
| Student > Ph. D. Student | 25 | 9% |
| Researcher | 22 | 8% |
| Student > Doctoral Student | 17 | 6% |
| Other | 43 | 16% |
| Unknown | 84 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 115 | 42% |
| Nursing and Health Professions | 21 | 8% |
| Biochemistry, Genetics and Molecular Biology | 7 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 2% |
| Psychology | 5 | 2% |
| Other | 18 | 7% |
| Unknown | 101 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#7,307,196
of 26,123,112 outputs
Outputs from Cochrane database of systematic reviews
#8,688
of 13,191 outputs
Outputs of similar age
#78,370
of 323,861 outputs
Outputs of similar age from Cochrane database of systematic reviews
#160
of 226 outputs
Altmetric has tracked 26,123,112 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 13,191 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.6. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,861 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 226 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.